Загрузка...
Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas
Despite substantially improved survival with rituximab-based treatment regimens, there is an unmet medical need for better treatments of B-cell lymphoma, particularly for patients with relapsed or refractory disease. Retreatment with rituximab exerts a limited effect in these patients, and platinum-...
Сохранить в:
| Опубликовано в: : | Blood Res |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8093997/ https://ncbi.nlm.nih.gov/pubmed/33935029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2021.2020320 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|